For the latest COVID-19 information for Massey, visit


Developmental Therapeutics

Program co-leaders

Program co-leaders

Steven Grant, M.D.

Anthony Faber, Ph.D.

Xiang-Yang (Shawn) Wang, Ph.D.

The Developmental Therapeutics (DT) program leverages basic discoveries emanating from Virginia Commonwealth University (VCU) Massey Cancer Center (MCC) laboratories as well as the extensive translational capabilities of its members to develop and implement innovative trials designed to improve the outcomes of patients with cancer. As such, the DT program represents an important vehicle through which novel therapeutic targets and strategies are identified and developed, and by which such discoveries, including those emanating from the Cancer Biology (CB) program, are translated into the clinic for patients with cancer.

The overarching scientific objectives of the DT program are to evaluate multiple new agents and/or rational combination regimens in patients with diverse hematologic or solid tumor malignancies. In addition, researchers DT members seek to identify biomarkers or pharmacodynamic determinants of disease responsiveness.

Scientific aims


View list of Developmental Therapeutics members

The searchable directory is comprised of VCU Massey Cancer Center’s full, associate and affiliate research members.

Search for Researchers